Copyright Reports & Markets. All rights reserved.

Global Codeine Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Ingredient
    • 1.3.1 Overview: Global Codeine Consumption Value by Ingredient: 2021 Versus 2025 Versus 2032
    • 1.3.2 Single-ingredient Codeine
    • 1.3.3 Multi-ingredient Medications
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Codeine Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Narcotic Analgesic
    • 1.4.3 Antitussive
    • 1.4.4 Others
  • 1.5 Global Codeine Market Size & Forecast
    • 1.5.1 Global Codeine Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Codeine Sales Quantity (2021-2032)
    • 1.5.3 Global Codeine Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Taiji
    • 2.1.1 Taiji Details
    • 2.1.2 Taiji Major Business
    • 2.1.3 Taiji Codeine Product and Services
    • 2.1.4 Taiji Codeine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Taiji Recent Developments/Updates
  • 2.2 Mallinckrodt
    • 2.2.1 Mallinckrodt Details
    • 2.2.2 Mallinckrodt Major Business
    • 2.2.3 Mallinckrodt Codeine Product and Services
    • 2.2.4 Mallinckrodt Codeine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Mallinckrodt Recent Developments/Updates
  • 2.3 TEVA
    • 2.3.1 TEVA Details
    • 2.3.2 TEVA Major Business
    • 2.3.3 TEVA Codeine Product and Services
    • 2.3.4 TEVA Codeine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 TEVA Recent Developments/Updates
  • 2.4 Johnson & Johnson
    • 2.4.1 Johnson & Johnson Details
    • 2.4.2 Johnson & Johnson Major Business
    • 2.4.3 Johnson & Johnson Codeine Product and Services
    • 2.4.4 Johnson & Johnson Codeine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Johnson & Johnson Recent Developments/Updates
  • 2.5 Medreich
    • 2.5.1 Medreich Details
    • 2.5.2 Medreich Major Business
    • 2.5.3 Medreich Codeine Product and Services
    • 2.5.4 Medreich Codeine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Medreich Recent Developments/Updates
  • 2.6 Sanofi Aventis
    • 2.6.1 Sanofi Aventis Details
    • 2.6.2 Sanofi Aventis Major Business
    • 2.6.3 Sanofi Aventis Codeine Product and Services
    • 2.6.4 Sanofi Aventis Codeine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Sanofi Aventis Recent Developments/Updates
  • 2.7 Cipla
    • 2.7.1 Cipla Details
    • 2.7.2 Cipla Major Business
    • 2.7.3 Cipla Codeine Product and Services
    • 2.7.4 Cipla Codeine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Cipla Recent Developments/Updates
  • 2.8 Hikma
    • 2.8.1 Hikma Details
    • 2.8.2 Hikma Major Business
    • 2.8.3 Hikma Codeine Product and Services
    • 2.8.4 Hikma Codeine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Hikma Recent Developments/Updates
  • 2.9 Pharmaceutical Associates
    • 2.9.1 Pharmaceutical Associates Details
    • 2.9.2 Pharmaceutical Associates Major Business
    • 2.9.3 Pharmaceutical Associates Codeine Product and Services
    • 2.9.4 Pharmaceutical Associates Codeine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Pharmaceutical Associates Recent Developments/Updates
  • 2.10 Novartis
    • 2.10.1 Novartis Details
    • 2.10.2 Novartis Major Business
    • 2.10.3 Novartis Codeine Product and Services
    • 2.10.4 Novartis Codeine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Novartis Recent Developments/Updates
  • 2.11 Apotex
    • 2.11.1 Apotex Details
    • 2.11.2 Apotex Major Business
    • 2.11.3 Apotex Codeine Product and Services
    • 2.11.4 Apotex Codeine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Apotex Recent Developments/Updates
  • 2.12 Mylan
    • 2.12.1 Mylan Details
    • 2.12.2 Mylan Major Business
    • 2.12.3 Mylan Codeine Product and Services
    • 2.12.4 Mylan Codeine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Mylan Recent Developments/Updates
  • 2.13 Aristo Pharma GmbH
    • 2.13.1 Aristo Pharma GmbH Details
    • 2.13.2 Aristo Pharma GmbH Major Business
    • 2.13.3 Aristo Pharma GmbH Codeine Product and Services
    • 2.13.4 Aristo Pharma GmbH Codeine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 Aristo Pharma GmbH Recent Developments/Updates
  • 2.14 Lannett Company
    • 2.14.1 Lannett Company Details
    • 2.14.2 Lannett Company Major Business
    • 2.14.3 Lannett Company Codeine Product and Services
    • 2.14.4 Lannett Company Codeine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 Lannett Company Recent Developments/Updates
  • 2.15 Laboratoire Riva
    • 2.15.1 Laboratoire Riva Details
    • 2.15.2 Laboratoire Riva Major Business
    • 2.15.3 Laboratoire Riva Codeine Product and Services
    • 2.15.4 Laboratoire Riva Codeine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.15.5 Laboratoire Riva Recent Developments/Updates

3 Competitive Environment: Codeine by Manufacturer

  • 3.1 Global Codeine Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Codeine Revenue by Manufacturer (2021-2026)
  • 3.3 Global Codeine Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Codeine by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Codeine Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Codeine Manufacturer Market Share in 2025
  • 3.5 Codeine Market: Overall Company Footprint Analysis
    • 3.5.1 Codeine Market: Region Footprint
    • 3.5.2 Codeine Market: Company Product Type Footprint
    • 3.5.3 Codeine Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Codeine Market Size by Region
    • 4.1.1 Global Codeine Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Codeine Consumption Value by Region (2021-2032)
    • 4.1.3 Global Codeine Average Price by Region (2021-2032)
  • 4.2 North America Codeine Consumption Value (2021-2032)
  • 4.3 Europe Codeine Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Codeine Consumption Value (2021-2032)
  • 4.5 South America Codeine Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Codeine Consumption Value (2021-2032)

5 Market Segment by Ingredient

  • 5.1 Global Codeine Sales Quantity by Ingredient (2021-2032)
  • 5.2 Global Codeine Consumption Value by Ingredient (2021-2032)
  • 5.3 Global Codeine Average Price by Ingredient (2021-2032)

6 Market Segment by Application

  • 6.1 Global Codeine Sales Quantity by Application (2021-2032)
  • 6.2 Global Codeine Consumption Value by Application (2021-2032)
  • 6.3 Global Codeine Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Codeine Sales Quantity by Ingredient (2021-2032)
  • 7.2 North America Codeine Sales Quantity by Application (2021-2032)
  • 7.3 North America Codeine Market Size by Country
    • 7.3.1 North America Codeine Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Codeine Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Codeine Sales Quantity by Ingredient (2021-2032)
  • 8.2 Europe Codeine Sales Quantity by Application (2021-2032)
  • 8.3 Europe Codeine Market Size by Country
    • 8.3.1 Europe Codeine Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Codeine Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Codeine Sales Quantity by Ingredient (2021-2032)
  • 9.2 Asia-Pacific Codeine Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Codeine Market Size by Region
    • 9.3.1 Asia-Pacific Codeine Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Codeine Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Codeine Sales Quantity by Ingredient (2021-2032)
  • 10.2 South America Codeine Sales Quantity by Application (2021-2032)
  • 10.3 South America Codeine Market Size by Country
    • 10.3.1 South America Codeine Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Codeine Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Codeine Sales Quantity by Ingredient (2021-2032)
  • 11.2 Middle East & Africa Codeine Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Codeine Market Size by Country
    • 11.3.1 Middle East & Africa Codeine Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Codeine Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Codeine Market Drivers
  • 12.2 Codeine Market Restraints
  • 12.3 Codeine Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Codeine and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Codeine
  • 13.3 Codeine Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Codeine Typical Distributors
  • 14.3 Codeine Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Codeine market size was valued at US$ 239 million in 2025 and is forecast to a readjusted size of US$ 163 million by 2032 with a CAGR of -5.4% during review period.
    Codeine is an opiate used to treat pain, coughing, and diarrhea. It is typically used to treat mild to moderate degrees of pain.
    Market competition is intense. Taiji, Mallinckrodt, TEVA, Johnson & Johnson, Medreich, Sanofi Aventis, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers. For the major company of Codeine, Taiji and Mallinckrodt accounted for about 16% market share respectively in recent years.
    This report is a detailed and comprehensive analysis for global Codeine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Ingredient and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Codeine market size and forecasts, in consumption value ($ Million), sales quantity (M Units), and average selling prices (USD/Unit), 2021-2032
    Global Codeine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (M Units), and average selling prices (USD/Unit), 2021-2032
    Global Codeine market size and forecasts, by Ingredient and by Application, in consumption value ($ Million), sales quantity (M Units), and average selling prices (USD/Unit), 2021-2032
    Global Codeine market shares of main players, shipments in revenue ($ Million), sales quantity (M Units), and ASP (USD/Unit), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Codeine
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Codeine market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Taiji, Mallinckrodt, TEVA, Johnson & Johnson, Medreich, Sanofi Aventis, Cipla, Hikma, Pharmaceutical Associates, Novartis, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Codeine market is split by Ingredient and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Ingredient, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Ingredient
    Single-ingredient Codeine
    Multi-ingredient Medications
    Market segment by Application
    Narcotic Analgesic
    Antitussive
    Others
    Major players covered
    Taiji
    Mallinckrodt
    TEVA
    Johnson & Johnson
    Medreich
    Sanofi Aventis
    Cipla
    Hikma
    Pharmaceutical Associates
    Novartis
    Apotex
    Mylan
    Aristo Pharma GmbH
    Lannett Company
    Laboratoire Riva
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Codeine product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Codeine, with price, sales quantity, revenue, and global market share of Codeine from 2021 to 2026.
    Chapter 3, the Codeine competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Codeine breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Ingredient and by Application, with sales market share and growth rate by Ingredient, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Codeine market forecast, by regions, by Ingredient, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Codeine.
    Chapter 14 and 15, to describe Codeine sales channel, distributors, customers, research findings and conclusion.

    Buy now